ConductScience.org, home

Paper6178545

Clinical pharmacokinetics of N-acetylprocainamide.

Connolly SJ and 1 other. Clin Pharmacokinet, 1982. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacokinetics of N-acetylprocainamide. Papers, record 6178545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6178545

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of N-acetylprocainamide.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Connolly SJS J
2Kates RER E

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcecainideMajor topic
Anti-Arrhythmia AgentsMajor topic
ProcainamideMajor topic
Aging
Biological Availability
Humans
Kinetics
Protein Binding

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16158263Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.Am J Cardiol1980https://conductscience.org/library/papers/6158263PubMed
2863987Quantitative thin-layer chromatographic method for the determination of procainamide and its major metabolite in plasma.J Chromatogr1977https://conductscience.org/library/papers/863987PubMed
3458558Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/458558PubMed
46160015Aging and renal clearance of procainamide and acetylprocainamide.Clin Pharmacol Ther1980https://conductscience.org/library/papers/6160015PubMed
56161089Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.Int J Clin Pharmacol Ther Toxicol1980https://conductscience.org/library/papers/6161089PubMed
6975731Hemodialysis for severe procainamide toxicity: clinical and pharmacokinetic observations.Clin Pharmacol Ther1976https://conductscience.org/library/papers/975731PubMed
71183141Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1183141PubMed
81151617Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1151617PubMed
991451Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.Circulation1979https://conductscience.org/library/papers/91451PubMed
106172888Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.Ther Drug Monit1981https://conductscience.org/library/papers/6172888PubMed
11643424Fetal uptake and neonatal disposition of procainamide and its acetylated metabolite: a case report.Pediatrics1978https://conductscience.org/library/papers/643424PubMed
126162598N-Acetyl-procainamide kinetics in the elderly.Clin Pharmacol Ther1981https://conductscience.org/library/papers/6162598PubMed
131002795Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.J Chromatogr1976https://conductscience.org/library/papers/1002795PubMed
146155064The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias.Am J Cardiol1980https://conductscience.org/library/papers/6155064PubMed
15872496Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.Clin Pharmacol Ther1977https://conductscience.org/library/papers/872496PubMed
16902457Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.Clin Pharmacol Ther1977https://conductscience.org/library/papers/902457PubMed
171261157N-Acetylprocainamide levels in patients with end-stage renal failure.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261157PubMed
181263131Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.J Pharmacol Exp Ther1976https://conductscience.org/library/papers/1263131PubMed
191185521Pharmacokinetics in man of the N-acetylated metabolite of procainamide.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1185521PubMed
204623713Metabolism of procainamide in rhesus monkey and man.Clin Pharmacol Ther1972https://conductscience.org/library/papers/4623713PubMed

See all 45 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
16841194Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.Pharm Res2006https://conductscience.org/library/papers/16841194PubMed
9098657Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.Drug Saf1997https://conductscience.org/library/papers/9098657PubMed
6194997Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6194997PubMed
3297463The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297463PubMed
2285495Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.Drug Saf1990https://conductscience.org/library/papers/2285495PubMed
2180615Therapeutic drug monitoring of antiarrhythmic drugs. Rationale and current status.Clin Pharmacokinet1990https://conductscience.org/library/papers/2180615PubMed
1693889Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.Drugs1990https://conductscience.org/library/papers/1693889PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6178545

GET https://conductscience.org/api/papers/v1/6178545/references?page=2